SK Square (402340) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Feb, 2026Executive summary
Achieved record-high consolidated operating income of KRW 8.8tn in 2025, up KRW 4.9tn year-over-year, driven by SK hynix and improved ICT portfolio performance.
Net income reached KRW 8.8tn, with NAV surging by KRW 69.1tn YoY to KRW 100.2tn, mainly due to SK hynix valuation gains.
Portfolio rebalancing included a stake exchange in IDQ for IONQ shares and divestments in Dreamus and Incross.
Set new corporate value-up goals for 2028, targeting NAV discount below 30%, PBR 1x+, and ROE above COE.
Financial highlights
Consolidated revenue was KRW 1.4tn, with operating income at KRW 8.8tn and net income at KRW 8.8tn for 2025.
Net cash position stood at KRW 769bn, with no unconsolidated debt.
Dividend income totaled KRW 356bn.
NAV per share reached KRW 758,786.
Outlook and guidance
SK hynix aims to maintain HBM market leadership and ramp up HBM4 production in 2026.
TMAP MOBILITY targets further growth in Mobility Data and AI Agent services in 2026.
SK shieldus plans to drive revenue and profitability by advancing AI-powered security services.
Latest events from SK Square
- Operating income and NAV hit record highs, supported by SK hynix gains and portfolio actions.402340
Q3 202510 Feb 2026 - AGM approved 2024 financials, new directors, and focused on profit recovery and governance.402340
AGM 2025 Presentation9 Feb 2026 - Operating and net income soared, with NAV up 23% on SK hynix gains; key segments outperformed.402340
Q2 20249 Feb 2026 - Record-high earnings and NAV driven by SK hynix, with upgraded ESG rating to 'A+'.402340
Q3 20249 Feb 2026 - Record operating income and NAV growth fueled by SK hynix and ICT portfolio performance.402340
Q1 20259 Feb 2026 - Record earnings, NAV growth, and robust segment results drive value and shareholder returns.402340
Q4 20249 Feb 2026 - Operating income and NAV surged, led by SK hynix and robust portfolio gains.402340
Q2 20259 Feb 2026